What is an Allograft definition types and immune response
Grafting is the surgical process. This is the process of transplanting live tissues from one part of the body to another, from one person to another, or from one species to another. During this process, it generates a new blood supply through the transplanted tissues. Depends on the types of transplantation, the acceptance and rejection rate varies. This completely depends on the donor and recipient’s characteristics.
Classification of Grafting
The graftings are classified according to the donor and recipient. Grafting is classified into four types. They are
Autograft → If the tissues or bones are transplanted from one part of the body to other parts of the body, within the same individual is Autograft.
Allograft → If the tissues/bones are transplanted from genetically different individuals, it is known as Allograft
Isograft → If the transplantation occurs between genetically identical individuals, ie. between identical twins, it is known as Isograft.
Xenograft → If the tissues/organ/bone transplantation occurs between the two different species, it is known as xenograft. For example between pig and human
Allograft Definition
Allograft meaning allogeneic transplantation or homograft. Allograft definition termed as the tissues or bones is transplanted between the genetically non identical individuals of the same species. Most of the donors and recipients of allografts may be relations. But allograft transplantation is possible only if both individuals have the same blood group. Allograft transplantation can commonly be used for the transplantations of skin, heart, liver, corneas, bone, bone marrow, and kidney.
Allogeneic Tissue
The allogeneic means that the single source of cells is used to treat many patients. During the allogeneic transplantation, a person’s stem cells are replaced with the new healthy stem cells. Allogeneic therapy increases the risk of bringing out an immune response from the patient, and immunosuppressive therapies along with some combinational therapies for providing allogeneic processes.
Types of Allogeneic Tissue
Depending on the type of stem cells acquisition, the allogeneic tissue is classified into four types. They are listed below.
Unmodified Stem Cell Transplant
T-Cell-Depleted Transplants
Cord Blood Transplants
Donor Lymphocyte Infusions (DLI)
Unmodified Stem Cell Transplant
During the unmodified, or conventional, stem cell transplantation. All the patients receive the stem cells as it is from the laboratory, without making any changes in it. These cells contain all immune cells like T cells. The unmodified stem cell transplants are better for people who have the risk of medicating the graft-versus-host disease.
T-Cell-Depleted Transplant
During the T-cell depleted transplants, the T cells in the stem cells are taken out with suitable equipment in the laboratory. As the T-cells in donor stem cells can cause graft-versus-host disease to patients. After the removal of T-cells from stem cells, it contains remaining cells like blood-forming stem cells are provided to the patients. Then, the new T cells can be provided to the patients, which are less effective to cause graft versus host disease than the T-cells in actual stem cells. This reduces the complication of taking medication for graft versus host disease after transplantation.
Cord Blood Transplant
The stem cells are taken from the umbilical cord and placenta of healthy newborn babies used for the cord blood transplant. Here, the chance of facing the risk of graft versus host disease after the coed blood transplantation is low. This is mainly because very close tissues in the umbilical cord match the patients and newborn donors. The people, who could not find the perfect matched donor can make use of Cord blood transplantation. The Memorial Sloan Kettering’s research explains well about cord blood transplantation.
Donor Lymphocyte Infusions (DLI)
People with certain types of cancer may come across stem cell transplantation. The physicians will slowly increase the amount of T-cells provided to the recipient from the donor. The controlled and minimum injecting of T cells has the ability to control the cancerous growth and reduces the risk of graft versus host disease.
Allograft Rejection
Allograft rejection is mainly due to the recipient’s alloimmune response and donor tissue’s nonself antigens expression. The allograft rejections are mainly of three types.
Hyperacute Rejection
Acute Rejection
Chronic Rejection
Hyperacute Rejection:
Hyperacute rejection occurs immediately after the transplantation. This is completely because of mismatched antigens. These tissues must be removed as soon as possible to avoid tissue death. Hyperacute rejections are most commonly observed when the donor or recipient is in a different blood group. Hyperacute rejection can be avoided by concentrating while choosing the right donor using ABO compatibility. Every blood group has the anti donor human leukocyte antigen (HLA), which acts on other blood groups.
Acute Rejection:
Acute rejection occurs at any time from the first week to 3 months after the transplantation. All the recipients experience a little percentage of acute rejection after transplantation. This acute rejection can be diagnosed by analyzing graft biopsy. This is mainly due to the immunological response of T cells and B cells.
Chronic Rejection:
Chronic rejection may occur or may not occur even after the year of transplantation. Mostly chronic rejection occurs during organ transplantation. The body's constant immune response against the organ leads to damage to the tissues or organs.
FAQs on Allograft in Biology and Transplantation
1. What is an allograft?
An allograft is a tissue or organ transplant taken from one individual and transplanted into another genetically different individual of the same species. In humans, this includes common procedures such as kidney, heart, or bone graft transplants between unrelated people.
- Donor and recipient belong to the same species.
- They are genetically non-identical.
- Allografts often require immunosuppressive therapy to prevent rejection.
2. What is the difference between allograft and autograft?
The main difference between an allograft and an autograft is that an autograft comes from the same individual, while an allograft comes from a different individual of the same species.
- Autograft: Tissue transferred within the same person (e.g., skin graft from thigh to arm).
- Allograft: Tissue transferred between two different individuals of the same species.
- Autografts rarely cause immune rejection, while allografts often do.
3. Why are allografts rejected by the immune system?
Allografts are rejected because the recipient’s immune system recognizes the donor tissue as foreign due to differences in major histocompatibility complex (MHC) molecules. These surface proteins vary between individuals and trigger an immune response.
- T lymphocytes detect non-self MHC antigens.
- This activates cell-mediated immunity.
- The graft tissue is attacked and damaged.
4. What are the types of graft rejection in allografts?
The three main types of allograft rejection are hyperacute, acute, and chronic rejection. Each type differs in timing and immune mechanism.
- Hyperacute rejection: Occurs within minutes to hours due to pre-existing antibodies.
- Acute rejection: Develops within days to weeks, mainly mediated by T cells.
- Chronic rejection: Occurs over months to years due to long-term immune damage.
5. How does tissue matching reduce allograft rejection?
Tissue matching reduces allograft rejection by ensuring compatibility between donor and recipient HLA (human leukocyte antigen) molecules. The closer the HLA match, the lower the immune response.
- HLA typing identifies compatible donors.
- Cross-matching checks for pre-existing antibodies.
- Better matching improves graft survival rates.
6. What are common examples of allografts in medicine?
Common examples of allografts include kidney transplants, heart transplants, and bone grafts between unrelated individuals. These procedures are widely used in modern medicine.
- Kidney allograft for end-stage renal disease.
- Heart allograft for severe heart failure.
- Bone allograft in orthopedic surgery.
7. What is the role of immunosuppressive drugs in allografts?
Immunosuppressive drugs prevent the recipient’s immune system from attacking the allograft. They reduce the activity of immune cells responsible for rejection.
- Inhibit T-cell activation.
- Suppress antibody production.
- Lower inflammation against donor tissue.
8. What is the difference between allograft and xenograft?
The key difference between an allograft and a xenograft is that an allograft occurs between members of the same species, while a xenograft occurs between different species. For example, a pig heart valve implanted into a human is a xenograft.
- Allograft: Human to human transplant.
- Xenograft: Animal to human transplant.
- Xenografts trigger stronger immune reactions.
9. Can an allograft be permanent?
An allograft can function long-term but is rarely permanent without medical management. Lifelong monitoring and immunosuppression are usually required.
- Some kidney allografts function for 15–20 years.
- Chronic rejection may gradually reduce function.
- Regular follow-up prevents complications.
10. What is the importance of allografts in biology and medicine?
Allografts are important because they enable life-saving organ and tissue transplantation between individuals of the same species. They are central to modern clinical practice and immunology research.
- Used in organ transplantation (kidney, liver, heart).
- Advance understanding of immune response and graft rejection.
- Improve survival in patients with organ failure.
